Tenon Medical, Inc. (TNON)

NASDAQ: TNON · USD

$2.27

+0.12 (+5.8%)· Recorded snapshot

Market cap	1.5M
Revenue (ttm)	5.3M
Net income (ttm)	-13.7M
EPS (ttm)	-$46.7
Shares out	667K
Volume	435,806
Beta	1.36

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 5.3M
Net income (ttm): -13.7M
EPS (ttm): -$46.7
Market cap: 1.5M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	نگه‌داری

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-551.2

P25 n/aP50 n/aP75 n/a

ROIC-138.4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All TNON indicators

Market & fundamental data

Available fields

201

Groups with data

Currency

USD

Showing 201 of 201 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001560293
Company name	Tenon Medical, Inc.
Country	United States
Country code	US
CUSIP number	88066N402
Earnings date	2026-11-12
Earnings time	amc
Employees	26
Employees change	-1
Employees growth	-3.7%
Enterprise value	$5.5M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2012
Industry	Medical Devices
IPO date	2022-04-27
Is primary listing	Yes
Is SPAC	No
ISIN number	US88066N4025
Last 10-K release date	2026-03-27
Last earnings date	2026-08-13
Last refreshed	2026-10-28
Last stock split date	2026-08-10
Last stock split type	Reverse
Market cap	$1.5M
Market cap category	Nano-Cap
Next earnings date	2026-11-12
Options	No
Price	$2.27
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-28
Symbol	TNON
U.S. state	California
Website	https://www.tenonmed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-2,060.59%
EV/Sales	1.03x
FCF / EV yield	-234.1%
FCF yield	-868.02%
Forward EV/Sales	0.82x
Forward P/S	0.22x
Industry forward P/E	19.81x
Industry P/E	39.5x
P/S ratio	0.28x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-228.03%
EBITDA margin	-222.1%
Gross margin	66.81%
Operating margin	-228.03%
Pretax margin	-257.85%
Profit margin	-257.85%
Profit per employee	$-526,808
Revenue per employee	$204,308
ROA	-71.98%
ROA (5Y)	-97.39%
ROCE	-749.1%
ROE	-551.19%
ROIC	-138.43%
SBC / revenue	21.55%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	2
EPS growth years	4
Gross profit growth	165.05%
Gross profit growth (Q)	232.24%
Gross profit growth 5Y	175.83%
Net income growth years	3
Revenue growth	80.25%
Revenue growth (Q)	126.77%
Revenue growth (QoQ)	-7.25%
Revenue growth 3Y	47.33%
Revenue growth 5Y	150.7%
Revenue growth quarters	4
Revenue growth years	5

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-1.1M
Depreciation and amortization	$315,000
EBIT	$-12.1M
EBITDA	$-11.8M
EPS	$-46.67
FCF per share	$-19.23
Financing cash flow	$6.7M
Free cash flow	$-12.8M
Free cash flow minus SBC	$-14M
Gross profit	$3.5M
Investing cash flow	$-1.1M
Net borrowing	$4.3M
Net cash flow	$-6.2M
Net income	$-13.7M
Operating cash flow minus SBC	$-12.9M
Operating income	$-12.1M
Revenue	$5.3M
Stock-based compensation	$1.1M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-15.96
Book value per share	$-14.57
Goodwill	$2.4M
Interest coverage	-11.78
Long-term assets	$5.1M
Long-term liabilities	$3.4M
Net cash (debt)	$-4M
Net cash / market cap	-270.79%
Piotroski F-Score	3
Property, plant and equipment	$2.2M
Shareholders' equity	$-1.7M
Tangible book value	$-7.7M
Tangible book value per share	$-23.22
Total assets	$9.9M
Total cash	$1.7M
Total debt	$5.7M
Total liabilities	$11.7M
WACC	13.77%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.51
Current assets	$4.8M
Current liabilities	$8.3M
Current ratio	0.58
Inventory turnover	2.4
Net working capital	$-628,000
Quick ratio	0.44
Working capital	$-3.5M
Working capital turnover	2.78

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-169.77%
Dividend yield	0%
Shareholder yield	-169.77%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$13.49
1D price change	5.84%
1M price change	-27.64%
1M total return	-27.64%
1W price change	-9.76%
1W total return	-9.76%
1Y price change	-94.7%
1Y return CAGR	-94.71%
1Y total return	-94.7%
20-day SMA	$2.91
200-day SMA	$17.41
3M price change	-64.85%
3M total return	-64.85%
3Y price change	-99.39%
3Y return CAGR	-81.7%
3Y total return	-99.39%
50-day SMA	$3.96
50-day SMA vs 200-day SMA	50under200
52-week high	$45.50
52-week high date	2025-11-12
52-week low	$2.10
52-week low date	2026-10-26
6M price change	-91.78%
6M total return	-91.78%
All-time high	$167,692.17
All-time high date	2022-05-10
All-time low	$2.10
All-time low date	2026-10-26
Average true range (ATR)	$0.42
Average volume	583.4K
Beta (1Y)	-1.84
Beta (2Y)	-0.01
Beta (5Y)	1.36
Change from 52-week high	-95.02%
Change from 52-week low	7.86%
Change from all-time high	-100%
Change from all-time low	7.86%
Change from open	1.57%
Day's gap	4.21%
Dollar volume	$987,101
High price	$2.27
Low price	$2.17
Monthly RSI	6.22
Open price	$2.23
Position in 52-week range	100%
Premarket change	4.21%
Premarket close	$2.14
Premarket price	$2.23
Premarket volume	224.8K
Previous close	$2.14
Price vs 150-day SMA	-83.21%
Price vs 20-day SMA	-22.27%
Price vs 200-day SMA	-86.99%
Price vs 50-day SMA	-42.75%
Relative volume	0.75
Return from IPO open	-100%
Return from IPO price	-55.7%
RSI	35.97
Sharpe ratio	-0.52
Sharpe ratio (3Y)	-0
Sortino ratio	-1.08
Sortino ratio (3Y)	0.03
Volume	435.8K
Weekly RSI	26.29
YTD price change	-93.2%
YTD total return	-93.2%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	613.9K
Float percentage	92.03%
Shares change (QoQ)	1.88%
Shares change (YoY)	169.77%
Shares held by insiders	4.84%
Shares held by institutions	6.62%
Shares outstanding	667K
Short % of float	8.44%
Short % of shares	7.77%

Deeper analysis on TNON

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TNON report

Is a complete TNON research report available?

No complete published report is available for Tenon Medical, Inc. (TNON) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Tenon Medical, Inc. (TNON)

Price

Financial snapshot

Fair-value bridge

Latest news · TNON

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TNON indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TNON

Frequently asked questions